Pain Relief (PR) Notes to Readers

Similar documents
Neuropathic Pain Scale (NPS)

Short-Form McGill Pain Questionniare-2 (SHORT-FORM MPQ-2)

Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Clinical Global Impression (CGI)

Disability Assessment for Dementia (DAD)

Hospital Anxiety and Depression Scale (HADS)

Brief Psychiatric Rating Scale-Anchored (BPRS-A)

Michigan Neuropathy Screening Instrument (MNSI)

Epworth Sleepiness Scale (ESS)

Brief Psychiatric Rating Scale-Anchored (BPRS-A)

Modified Hachinski Ischemic Scale: NACC Version (MHIS-NACC) v.1.0

Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Hamilton Depression Rating Scale 17-Item (HAMD 17)

Barnes Akathisia Rating Scale (BARS)

Timed Up and Go (TUG)

Unified Parkinson's Disease Rating Scale UPDRS

Unified Parkinson's Disease Rating Scale UPDRS

Alzheimer s Disease-specific Therapeutic Area Supplement to the Study Data Tabulation Model User Guide

PharmaSUG Paper DS04

CDISC BrCa TAUG & Oncology Information Session

PharmaSUG Paper DS12

Let s Create Standard Value Level Metadata

Therapeutic Area User Guide Cardiovascular V1.0 Public Review Webinar April 3, 2014

Project Charter. Template v2 June 3, February 25, Name of Project: Prostate Cancer (PrCa) Therapeutic Area Data Standards

SDTMIG v3.3 Batch 2 Upcoming Public Review. Presented by Fred Wood

Intervention ML: Mapping of Meal data. Rahul Loharkar, inventiv Health Clinical, Pune, India Sandeep Sawant, inventiv Health Clinical, Mumbai, India

Jerry Salyers, Accenture Accelerated R&D Services Fred Wood, Accenture Accelerated R&D Services. PhUSE 2017 Edinburgh, Scotland Paper #DS05

How to manage changes to CDISC standards at Novo Nordisk. PhUSE EU Connect 2018 Sune Dandanell and Mikkel Traun

CDISC - Mapping New Pathways for Novartis. Darren Weston, Project Leader Pat Majcher, Senior Principal Programmer

Design and Construct Efficacy Analysis Datasets in Late Phase Oncology Studies

The Standard for the Exchange of Nonclinical Data (SEND): History, Basics, and Comparisons with Clinical Data

CFAST Asthma Project. Rhonda Facile. CDISC International Interchange Session 4B: Therapeutic Area Standards in Action November 6, 2013

Therapeutic Area Data Standards User Guide for Cardiovascular Studies Version 1.0 (Provisional) Prepared by the CFAST Cardiovascular Team

Examples: Tables. Descriptive stats with ANOVA, ANCOVA, and t test p values Frequency and percent Correlation coefficients

CDISC Public Webinar- Post Traumatic Stress Disorder Therapeutic Area User Guide

ADaM Considerations and Content in the TA User Guides. Susan J Kenny, PhD Maximum Likelihood, Inc.

Breast Cancer TAUG Overview and Implementation

Data Management and CDISC Formatting for Transdermal Patches Lois Lynn, Noven Pharmaceuticals, Inc., Jersey City, NJ

Institute of Medicine Workshop: DIGITAL DATA PRIORITIES FOR CONTINUOUS LEARNING IN HEALTH AND HEALTH CARE

CDISC CONTROLLED TERMINOLOGY. Presented by Chris Gemma and Erin Muhlbradt, Ph.D.

CDISC Controlled Terminology. Presented by Chris Gemma and Erin Muhlbradt, Ph.D.

Grading Lab Toxicities using NCI- Common Terminology Criteria for Adverse Events (CTCAE)

in the ICH Regions Table of Content Annexes to Guideline and 3. Why is Q4B necessary? Q4B Annexes? for Human Use

PharmaSUG 2018 Paper AD-02

Study Endpoint Considerations: Final PRO Guidance and Beyond

Graph Display of Patient Profile Using SAS

Authors and Co-Authors,

Scientific Working Group on Digital Evidence

A critical appraisal of: Canadian guideline fysisk aktivitet using the AGREE II Instrument

CDISC SHARE. CDISC Shared Health and Research Electronic Library Pilot Report. Date: 19 January 2010 Version: 1.0 CDISC, 2010

British Columbia Data Standards

Global Harmonization Task Force SG3 Comments and Recommendations ISO/DIS 9001: 2000 and ISO/DIS 9000: 2000 And Revision of ISO and 13488

BEST PRACTICES FOR IMPLEMENTATION AND ANALYSIS OF PAIN SCALE PATIENT REPORTED OUTCOMES IN CLINICAL TRIALS

CDISC Public Webinar- Huntington's Disease Therapeutic Area User Guide

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

ADaM Grouping: Groups, Categories, and Criteria. Which Way Should I Go?

Request for Proposals

Critical Path Institute Coalition Against Major Diseases (CAMD) Alzheimer s Clinical Trial Database

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

Standards for Analyzable Submission Datasets for Directed Safety Analyses

How to - Trial Summary Parameter. CJUG SDTM Team : LISaS

ISA 540, Auditing Accounting Estimates, Including Fair Value Accounting Estimates, and Related Disclosures Issues and Task Force Recommendations

IAASB Main Agenda (March 2005) Page Agenda Item. DRAFT EXPLANATORY MEMORANDUM ISA 701 and ISA 702 Exposure Drafts February 2005

Clinical Review Report (Sample)

DENOMINATOR: All patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period

Cancer Chemotherapy in Clinical Practice

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

Cochrane Breast Cancer Group

Measure #355: Unplanned Reoperation within the 30 Day Postoperative Period National Quality Strategy Domain: Patient Safety

ADaM Tips for Exposure Summary

SDTM, Implementation Guide, and User Guide Updates

Standards for the reporting of new Cochrane Intervention Reviews

Row same as start date 513) Examples for Treatments Major Issue Closed

WELSH INFORMATION STANDARDS BOARD

TRANSLATION. Montreal, April 11, 2011

ALL PRINCIPAL INVESTIGATORS/NURSES/DATA MANAGERS RE: PROTOCOL GOG-0233 ACRIN 6671, REVISION # 9 & #10

UPDATE ON PREMARKET TOBACCO PRODUCT AUTHORIZATION PATHWAY

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

EFSA PRE-SUBMISSION GUIDANCE FOR APPLICANTS INTENDING TO SUBMIT APPLICATIONS FOR AUTHORISATION OF HEALTH CLAIMS MADE ON FOODS

A SAS sy Study of ediary Data

COGNITIVE FUNCTION. PROMIS Pediatric Item Bank v1.0 Cognitive Function PROMIS Pediatric Short Form v1.0 Cognitive Function 7a

Using CDISC Models for the Analysis of Safety Data

EVIDENCE IN BRIEF OVERALL CLINICAL BENEFIT

DRAFT (Final) Concept Paper On choosing appropriate estimands and defining sensitivity analyses in confirmatory clinical trials

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Immediate-release Hydrocodone/Acetaminophen M Abbreviated Clinical Study Report R&D/08/1020

OVERALL CLINICAL BENEFIT

Understanding test accuracy research: a test consequence graphic

FURNITURE TERMS / POLICIES. TERMS OF FURNITURE SALE [agreement is required with all orders] FURNITURE ORDERS

PRSB e-discharge summary phase 2 Medications and medical devices information model

Where Is the Link Broken Another Look at SDTM Oncology Tumor Packages

Mental health practitioners working in medicine represent the vanguard

Measure #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

HOW IS PACE TO BE USED

Broad and clinically important benefits beyond the initial registrational endpoints are now reported.

GOOD PHARMACOPOEIAL PRACTICES

CONSORT 2010 checklist of information to include when reporting a randomised trial*

IAF Mandatory Document. Requirements for the Migration to ISO 45001:2018 from OHSAS 18001:2007 (IAF MD 21:2018)

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Transcription:

Pain (PR) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC and Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) Notes to Readers This implementation guide is intended to be used with other CDISC User Guides for specific Therapeutic/Disease Areas and follows the CDISC Study Data Tabulation Model Implementation Guide for Human Clinical trials. 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 1

Revision History Date Version Summary of Changes 2012-03-03 0.1 Pain (included in the NV domain for public review) 2012-08-07 1.0 Pain 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 2

1 Introduction This document describes the CDISC implementation of the Pain questionnaire, a standard public domain questionnaire administered on a CRF that is typically used in clinical trials to measure pain response. Please refer to the CDISC Pain Standards User Guide (http://www.cdisc.org/therapeutic) for information on developing this data standard by the sponsor, Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) and their working group, STandardized ANalgesic DAtabase for Research, Discovery, and Submissions (STANDARDS). The Pain concept preceded the CDISC CDASH CRF standards and has no standard CRF, based on its public domain status. CDASH standard CRFs may be developed in the future. The representation of data collected for this questionnaire is based on the Study Data Tabulation Model Implementation Guide (SDTMIG) QS domain table (SDTMIG), which can be found at the CDISC website at http://www.cdisc.org/sdtm. These implementation details for this specific questionnaire are meant to be used in conjunction with the SDTMIG, but are recorded separately since this questionnaire may be used in many different therapeutic area implementations. All questionnaire documentation can be found on the CDISC web site (http://www.cdisc.org/content2909). The CDISC Intellectual Property Policy can be found in the ABOUT CDISC/Bylaws & Policies section of the web site. 1.1 Representations and Warranties, Limitations of Liability, and Disclaimers This document is a supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials and is covered under Appendix F of that document, which describes representations, warranties, limitations of liability, and disclaimers. Please see Appendix F of the SDTMIG for a complete version of this material. 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 3

2 Copyright Status This instrument is in the public domain. CDISC has included the general Pain concepts as part of CDISC Data Standards. This means that CDISC developed QSCAT, QSTESTCD and QSTEST for the questions based on the actual question text on the questionnaire. There may be many versions of this questionnaire in the public domain. CDISC has chosen to use this version as the data standard. The CDISC documentation of this instrument consists of: (1) controlled terminology, (2) standard database structure with examples and (3) case report forms annotated with the CDISC SDTMIG submission values are not available, due to the general Pain concepts not having a published standard CRF. Note: CDISC controlled terminology is maintained by NCI EVS. The most recent version should be accessed through the CDISC website. (http://www.cdisc.org/terminology) CDISC has developed this documentation at no cost to users of the instrument. Reference: Handbook of Pain Assessment, Third Edition [Hardcover] Chapter 2 - Self-Report Scales and Procedures for Assessing Pain in Adults: Dennis C. Turk PhD (Editor), Ronald Melzack PhD (Editor) http://www.amazon.com/dp/1606239767/ref=rdr_ext_tmb) This definitive clinical reference comprehensively reviews the most advanced methods for assessing the person in pain. The field's leading authority s present essential information and tools for evaluating psychosocial, behavioral, situational, and medical factors in patients' subjective experience, functional impairment, and response to treatment. Empirically supported instruments and procedures are detailed, including self-report measures, observational techniques, psychophysiological measures, and more. Best-practice recommendations are provided for assessing the most prevalent pain syndromes and for working with children, older adults, and people with communication difficulties. The book also weighs in on the limitations of existing methods and identifies key directions for future research. CDISC acknowledges Dennis Turk and Ronald Melzack for inclusion of the Pain concepts as part of the CDISC SDTM Data standards. 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 4

3 The QS Domain Model 3.1 Assumptions for the Pain Questionnaire Domain Model All assumptions for the QS domain from the SDTMIG apply for this supplemental implementation guide including those referenced in the CDISC notes. Additionally, the following assumptions apply to Pain : 1. The questions relevant to measurement of Pain are in the public domain and routinely used in a variety of Pain/Analgesic condition studies. The Pain measures are a rating of the relief of pain at specified time points. Visual analog or numeric rating scales used within a questionnaire with a range of text and numeric values are indicated in the SUPPQS domain with: QNAM=RNGTXTLO QNAM=RNGTXTHI QNAM=RNGVALLO QNAM=RNGVALHI By storing this information in SUPPQS, it is available for interpretation purposes. The SDS QS Team is researching alternative methods to handle this data, but until a new method is identified, this will be the agreed approach. Pain is usually measured in a verbal rating scale with a categorical list of text and numeric values that are indicated in the SUPPQS domain as described above. For a verbal scale, the subject selects a descriptive phrase. Since the design of Pain/Analgesic studies is continually evolving, often using different numeric values for the same text values across drug projects and studies, the STANDARDS Working Group realized that further terminology standardization in the Pain Therapeutic Area will be needed on an ongoing basis. Such additional future terminology standards, where applicable, may be addressed by ACTTION in subsequent versions. CDISC and the ACTTION working group have suggested draft terminology for these pain scales. At the current time, standardization of these terms for data pooling will need to be performed in analysis datasets using the CDISC Analysis Data Model (ADaM) and the Statistical Analysis Plan (SAP). 2. Pain assessments include a variety of types of measurements beyond relief in general. This is normally specified in the question being asked as Rate your pain relief. Individual Pain test codes and test names are defined for each of these Pain questions. Pain Average Pain Least Pain Worst Pain 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 5

Minimum Pain Maximum Pain 3. The following Pain measures are also used in specific pain condition studies and are illustrated in the example below. This is normally specified in individual questions. Individual Pain test codes and test names are defined for each of these pain relief questions. Starting Pain at Least 1/2 Gone Time to Perceptible Pain Was there Perceptible Pain Time to Meaningful Pain Was there Meaningful Pain 4. The location of pain relief is populated in QSLOC with CDISC Location Terminology indicating the anatomical location when specified in a study. If multiple pain relief locations are specified separately at the same time point, separate records will be created for each anatomical location in order to enable analysis for each location. When a study is conducted for a specific type of overall pain (.ex Fibromyalgia, Diabetic Neuropathy, etc.), the Medical History MHTERM for the MHCAT=PRIMARY DIAGNOSIS will indicate the type and time reference of pain historically observed. Refer to the Pain Standards User Guide (http://www.cdisc.org/therapeutic) for a data example of this MH record. If this is not captured, the Trial Summary domain would contain an indication parameter to define the pain being investigated in the study. 1. Pain is relief at the time the question is asked. All the other test names above imply a period of time. For example, Least Pain in the last week could easily have a different value from Least Pain in the last year. This period of time should be clear in the data collection and, if it is, should be represented in the SDTM dataset as described below. The time period of evaluation of Pain is populated in the QSEVLINT field in ISO 8601 format when the evaluation interval can be precisely described as a duration as shown in examples a-c below. Specific points in time should use the QSDTC field as shown in example d. In cases where the evaluation interval cannot be precisely described as an ISO 8601 duration, the evaluation period should be represented using the Supplemental Qualifier EVLINTTX, as shown in examples e-g. In cases that are related to protocol-specified points in time, the QSTPT variable may be used as in example h. a. over last 24 hours QSEVLINT = -PT24H b. over last hour QSEVLINT = -PT1H c. over last week QSEVLINT = -P1W 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 6

d. right now QNAM=EVLINTTX QVAL= right now e. over the last night s sleep QNAM=EVLINTTX QVAL= Over last Night s Sleep f. Starting Pain is measured from the beginning of treatment QNAM=EVLINTTX QVAL= Pain from beginning of treatment g. since last medication: - QNAM=EVLINTTX QVAL= Since last medication h. At use of rescue medication this type of CRF is usually supplied at non-scheduled time point when rescue medication is administered to assist in relieving pain. The CDISC visit field is populated with VISIT= study design VISIT value QSTPT= Rescue Medication as a planned time point 5. Frequency/Timing of Pain measures captured in a study is normally included in the protocol s table of time and events (e.g., Hourly, Multiple times per day, periodic, etc.) For example, a rating of pain relief in the past 24 hours could be administered every day or once each week, and a rating of average pain relief in the past 7 days could be administered every week or once a month. The CDISC Trial Design model represents information about the protocol as parameters in the Trial Summary domain, and a terminology request is being submitted for the TSPARMCD=RATNGFRQ and TSPARM=Frequency of Rating Capture to address this need. CDISC will announce an alternative if one is determined to be necessary upon further investigation. 6. Activity during Pain measurements is populated in SUPPQS with QNAM=MOVETYP and QLABEL = values provided below. A. Not specified B. At rest C. With Movement 7. The evaluator of the questionnaire is stored in QSEVAL and for the Pain the Subject provides the evaluation of pain relief. 8. Terminology A. Requests for controlled terminology for the QSCAT, QSTESTCD, QSTEST and QSMETHOD variables are being submitted through the CDISC controlled terminology process. Controlled terminology is still under development for the Pain data standards, thus some values in the examples are not CDISC controlled terms. Verify demonstrated terminology against current standards before adopting it. B. Controlled terminology code lists are being submitted for the VERBAL RATING SCALE 6-POINT value lists as displayed in section 4. C. The specific mapping strategy for Pain using standard QS fields is described in Section 4: Mapping Strategy for the following required fields. 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 7

Section 4 provides guidance on how the result and category variables in the QS domain need to be populated for a questionnaire. (ex. QSORRES, QSORRESU, QSSTRESC, QSSTRESN, QSSTRESU, QSCAT and QSMETHOD) If a result variable is not included in the table for a questionnaire, it should not be populated. D. SUPPQS is used for additional data standardization with those data items listed in the Appendix C: Supplemental Qualifiers. 3.2 Examples for Pain Domain Model Example 1: 5-Point Verbal Rating Scale This example shows data from one subject collected at three visits for a Back Pain 5-Point Rating Scale questionnaire evaluated over the past 24 hours. The example uses standard controlled terminology for QSTESTCD, QSTEST, QSCAT, QSMETHOD and QSLOC for the Pain scale. QSSTRESN will be set to the standard numeric value and then converted into QSSTRESC. SUPPQS is populated with the data range text and numeric values. Rows 1-3: qs.xpt Represent 3 visit values of Back Pain ratings for USUBJID= from a Pain 5-Point Rating Scale Form. All original results are represented in QSORRES, which is then transformed into a Standard Numeric rating QSSTRESN, which is then also copied to a standard character value in QSSTRESC. Row STUDYID DOMAIN USUBJID QSSEQ QSTESTCD QSTEST QSCAT QSORRES QSSTRESC QSSTRESN QSMETHOD 1 STUDYX QS PR01 - Pain A LITTLE VERBAL RATING SCALE 5-1 PR01001 1 1 POINT 2 STUDYX QS PR01 - Pain VERBAL RATING SCALE 5-2 PR01001 SOME 2 2 POINT 3 STUDYX QS PR01 - Pain A LOT OF VERBAL RATING SCALE 5-3 PR01001 3 3 POINT Row QSLOC QSEVAL VISITNUM QSDTC QSDY QSEVLINT 1 (cont d) BACK SUBJECT 1 2004-01-03 1 -PT24H 2 (cont d) BACK SUBJECT 2 2004-01-09 7 -PT24H 3 (cont d) BACK SUBJECT 3 2004-01-16 14 -PT24H The data range text and numeric values for data collection values need to be populated in SUPPQS. These data range values for Pain are mapped to SUPPQS domain as follows. The standard terminology for QNAM and QLABEL are listed below. suppqs.xpt STUDYID RDOMAIN USUBJID IDVAR IDVARVAL QNAM QLABEL QVAL QORIG QEVAL 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 8

STUDYX QS QSSEQ 1 RNGTXTLO Range Text Lo NO CRF STUDYX QS QSSEQ 1 RNGTXTHI Range Text Hi COMPLETE CRF STUDYX QS QSSEQ 1 RNGVALLO Range Value Lo 0 CRF STUDYX QS QSSEQ 1 RNGVALHI Range Value HI 4 CRF STUDYX QS QSSEQ 2 RNGTXTLO Range Text Lo NO CRF STUDYX QS QSSEQ 2 RNGTXTHI Range Text Hi COMPLETE CRF STUDYX QS QSSEQ 2 RNGVALLO Range Value Lo 0 CRF STUDYX QS QSSEQ 2 RNGVALHI Range Value HI 4 CRF STUDYX QS QSSEQ 3 RNGTXTLO Range Text Lo NO CRF STUDYX QS QSSEQ 3 RNGTXTHI Range Text Hi COMPLETE CRF STUDYX QS QSSEQ 3 RNGVALLO Range Value Lo 0 CRF STUDYX QS QSSEQ 3 RNGVALHI Range Value HI 4 CRF Example 2: 5-Point Verbal Rating Scale This example shows data from one subject collected at three visits for a Worst Back Pain 5-Point Verbal Rating Scale questionnaire evaluated over the past 24 hours. The example uses standard controlled terminology for QSTESTCD, QSTEST, QSCAT, QSMETHOD and QSLOC for the Pain scale. QSSTRESN will be set to the standard numeric value and then converted into QSSTRESC. Rows 1-3: Represent 3 visit values of Worst Back Pain for USUBJID= from a Pain 5-Point Verbal Rating Scale Form. All original results are represented in QSORRES, which is then transformed into a Standard Numeric rating QSSTRESN, which is then also copied to a standard character value in QSSTRESC. SUPPQS is populated with the data range text and numeric values. qs.xpt Row STUDYID DOMAIN USUBJID QSSEQ QSTESTCD QSTEST QSCAT QSORRES QSSTRESC QSSTRESN QSMETHOD 1 STUDYX QS PR01 - Worst Pain VERBAL RATING SCALE 5-1 PR01006 A LITTLE 1 1 POINT 2 STUDYX QS PR01 - Worst Pain VERBAL RATING SCALE 5-2 PR01006 SOME 2 2 POINT 3 STUDYX QS PR01 - Worst Pain COMPLETE VERBAL RATING SCALE 5-3 PR01006 4 4 POINT Row QSLOC QSEVAL VISITNUM QSDTC QSDY QSEVLINT 1 (cont d) BACK SUBJECT 1 2004-01-03 1 PT0H 2 (cont d) BACK SUBJECT 2 2004-01-09 7 -PT24H 3 (cont d) BACK SUBJECT 3 2004-01-16 14 -PT24H The data range text and numeric values for data collection values need to be populated in SUPPQS. These data range values for Pain are mapped to SUPPQS domain as follows. The standard terminology for QNAM and QLABEL are listed below. 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 9

suppqs.xpt STUDYID RDOMAIN USUBJID IDVAR IDVARVAL QNAM QLABEL QVAL QORIG QEVAL STUDYX QS QSSEQ 1 RNGTXTLO Range Text Lo NO CRF STUDYX QS QSSEQ 1 RNGTXTHI Range Text Hi COMPLETE CRF STUDYX QS QSSEQ 1 RNGVALLO Range Value Lo 0 CRF STUDYX QS QSSEQ 1 RNGVALHI Range Value HI 4 CRF STUDYX QS QSSEQ 2 RNGTXTLO Range Text Lo NO CRF STUDYX QS QSSEQ 2 RNGTXTHI Range Text Hi COMPLETE CRF STUDYX QS QSSEQ 2 RNGVALLO Range Value Lo 0 CRF STUDYX QS QSSEQ 2 RNGVALHI Range Value HI 4 CRF STUDYX QS QSSEQ 3 RNGTXTLO Range Text Lo NO CRF STUDYX QS QSSEQ 3 RNGTXTHI Range Text Hi COMPLETE CRF STUDYX QS QSSEQ 3 RNGVALLO Range Value Lo 0 CRF STUDYX QS QSSEQ 3 RNGVALHI Range Value HI 4 CRF Example 3: Pain Rating and General Pain Questions collected in a Surgical Condition Study This example is based on a legacy sponsor specific CRF, in which the Pain Intensity measure is taken prior to dosing and then at hour readings. The Pain results are also obtained at specific hour time points for Pain and Starting Pain ½ Gone. At the end of the Pain capture, the following questions were asked for Was there meaningful pain relief, Time to meaningful pain relief, Was there perceptible pain relief, and the Time to perceptible pain relief. This example shows data from one subject collected with data collected at hour time points indicated with QSTPT=Pre-Treatment, 1H, 2H, 4H, & 6H collecting the following fields: 1. Pain 5-Point Verbal Rating Scale 2. Starting Pain at Least ½ Gone 3. Time to Perceptible Pain 4. Was there Perceptible Pain 5. Time to Meaningful Pain 6. Was there Meaningful Pain 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 10

The example uses standard controlled terminology for QSTESTCD, QSTEST, QSCAT, QSMETHOD and QSLOC for the Pain scale. QSSTRESN will be set to the standard numeric value and then converted into QSSTRESC for the Verbal Rating Scale 5-Point. SUPPQS is populated with the data range text and numeric values. Rows 1-12: qs.xpt Represent hour specific time point collection of Pain and General Pain questions for USUBJID=. All original results are represented in QSORRES, which is then transformed into a standard numeric rating QSSTRESN for the verbal rating scale 5-point, which is then also copied to a standard character value in QSSTRESC. Row STUDYID DOMAIN USUBJID QSSEQ QSTESTCD QSTEST QSCAT QSORRES QSORRESU QSSTRESC QSSTRESN QSSTRESU QSMETHOD VERBAL PR01 - Pain 1 STUDYX QS 1 PR01001 NO 0 0 RATING SCALE 5-POINT 2 STUDYX QS 3 STUDYX QS 4 STUDYX QS 5 STUDYX QS 6 STUDYX QS 7 STUDYX QS 8 STUDYX QS 9 STUDYX QS 10 STUDYX QS 11 STUDYX QS 12 STUDYX QS 2 PR01007 3 PR01001 4 PR01007 5 PR01001 6 PR01007 7 PR01001 8 PR01007 9 PR01008 10 PR01009 11 PR01010 12 PR01011 PR01 - Starting Pain at Least 1/2 Gone PR01 - Pain PR01 - Starting Pain at Least 1/2 Gone PR01 - Pain PR01 - Starting Pain at Least 1/2 Gone PR01 - Pain PR01 - Starting Pain at Least 1/2 Gone PR01 - Was there Perceptible Pain PR01 - Time to Perceptible Pain PR01 - Was there Meaningful Pain PR01 - Time to Meaningful N N NO 0 0 N N SOME Y Y A LOT OF Y Y Y Y 2 2 3 3 240 MIN 240 240 MIN Y Y 360 MIN 360 360 MIN VERBAL RATING SCALE 5-POINT VERBAL RATING SCALE 5-POINT VERBAL RATING SCALE 5-POINT 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 11

Row STUDYID DOMAIN USUBJID QSSEQ QSTESTCD QSTEST QSCAT QSORRES QSORRESU QSSTRESC QSSTRESN QSSTRESU QSMETHOD Pain Row QSLOC QSEVAL VISITNUM QSDTC QSDY QSTPT QSTPTREF 1 (cont d) BACK SUBJECT 1 2004-01-03T13:00 1 P1H Initial Dose 2 (cont d) BACK SUBJECT 1 2004-01-03T13:00 1 P1H Initial Dose 3 (cont d) BACK SUBJECT 1 2004-01-03T14:00 1 P2H Initial Dose 4 (cont d) BACK SUBJECT 1 2004-01-03T14:00 1 P2H Initial Dose 5 (cont d) BACK SUBJECT 1 2004-01-03T16:00 1 P4H Initial Dose 6 (cont d) BACK SUBJECT 1 2004-01-03T16:00 1 P4H Initial Dose 7 (cont d) BACK SUBJECT 1 2004-01-03T18:00 1 P6H Initial Dose 8 (cont d) BACK SUBJECT 1 2004-01-03T18:00 1 P6H Initial Dose 9 (cont d) BACK SUBJECT 1 2004-01-03T18:00 1 P6H Initial Dose 10 (cont d) BACK SUBJECT 1 2004-01-03T18:00 1 P6H Initial Dose 11 (cont d) BACK SUBJECT 1 2004-01-03T18:00 1 P6H Initial Dose 12 (cont d) BACK SUBJECT 1 2004-01-03T18:00 1 P6H Initial Dose The data range text and numeric values for data collection values need to be populated in SUPPQS. These data range values for Pain are mapped to SUPPQS domain as follows. The standard terminology for QNAM and QLABEL are listed below. suppqs.xpt STUDYID RDOMAIN USUBJID IDVAR IDVARVAL QNAM QLABEL QVAL QORIG QEVAL STUDYX QS QSSEQ 1 RNGTXTLO Range Text Lo NO CRF STUDYX QS QSSEQ 1 RNGTXTHI Range Text Hi COMPLETE CRF STUDYX QS QSSEQ 1 RNGVALLO Range Value Lo 0 CRF STUDYX QS QSSEQ 1 RNGVALHI Range Value HI 4 CRF STUDYX QS QSSEQ 3 RNGTXTLO Range Text Lo NO CRF STUDYX QS QSSEQ 3 RNGTXTHI Range Text Hi COMPLETE CRF STUDYX QS QSSEQ 3 RNGVALLO Range Value Lo 0 CRF STUDYX QS QSSEQ 3 RNGVALHI Range Value HI 4 CRF STUDYX QS QSSEQ 5 RNGTXTLO Range Text Lo NO CRF STUDYX QS QSSEQ 5 RNGTXTHI Range Text Hi COMPLETE CRF STUDYX QS QSSEQ 5 RNGVALLO Range Value Lo 0 CRF STUDYX QS QSSEQ 5 RNGVALHI Range Value HI 4 CRF STUDYX QS QSSEQ 7 RNGTXTLO Range Text Lo NO CRF STUDYX QS QSSEQ 7 RNGTXTHI Range Text Hi COMPLETE CRF STUDYX QS QSSEQ 7 RNGVALLO Range Value Lo 0 CRF STUDYX QS QSSEQ 7 RNGVALHI Range Value HI 4 CRF 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 12

4 SDTM Mapping Strategy Pain specific mapping strategy: This section is used to understand the alignment of the questionnaire to the SDTM QS domain. It also provides guidance on how the result variables (QSORRES, QSORRESU, QSSTRESC, QSSTRESN, and QSSTRESU) should be populated for each questionnaire. If a result variable is not included in the table for a questionnaire, it should not be populated. QSCAT Pain QSTESTCD/QSTEST Proposed Terminology QSTESTCD QSTEST PR01001 PR01 - Pain PR01002 PR01 - Average Pain PR01003 PR01 - Pain Minimum PR01004 PR01 - Pain Maximum PR01005 PR01 - Pain Least PR01006 PR01 - Pain Worst PR01007 PR01 - Starting Pain at Least 1/2 Gone PR01008 PR01 - Was there Perceptible Pain PR01009 PR01 - Time to Perceptible Pain PR01010 PR01 - Was there Meaningful Pain PR01011 PR01 - Time to Meaningful Pain QSMETHOD VERBAL RATING SCALE 5-POINT SUPPQS QVAL value standardization for data range text values QNAM QVAL RNGTXTLO NO RNGTXTHI COMPLETE QSCAT= QSMETHOD = VERBAL RATING SCALE 5-POINT QSTEST = Pain QSORRES QSSTRESC QSSTRESN NO 0 0 A LITTLE 1 1 SOME 2 2 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 13

A LOT OF 3 3 COMPLETE 4 4 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 14

SUPPLEMENTAL QUALIFIERS NAME CODES The following table contains an additional standard name codes for use in the Supplemental Qualifiers for Questionnaires (SUPPQS) special-purpose datasets... QNAM QLABEL Applicable Domains RNGTXTLO Range Text Lo QS RNGTXTHI Range Text Hi QS RNGVALLO Range Value Lo QS RNGVALHI Range Value Hi QS EVLINTTX Evaluation Time Reference Description QS MOVETYP Movement QS End of Document 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 15